Financial results - MEDITRINA PHARMACEUTICALS S.R.L.

Financial Summary - Meditrina Pharmaceuticals S.r.l.
Unique identification code: 22968491
Registration number: J2007024093405
Nace: 4646
Sales - Ron
7.892.537
Net Profit - Ron
348.289
Employees
37
Open Account
Company Meditrina Pharmaceuticals S.r.l. with Fiscal Code 22968491 recorded a turnover of 2024 of 7.892.537, with a net profit of 348.289 and having an average number of employees of 37. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Meditrina Pharmaceuticals S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.969.184 2.256.275 3.199.324 3.721.524 3.789.265 3.975.955 4.841.582 6.411.978 9.170.729 7.892.537
Total Income - EUR 2.016.143 2.284.719 3.258.374 3.739.535 3.823.117 4.010.059 4.878.833 6.433.144 9.213.315 8.043.848
Total Expenses - EUR 1.987.521 2.254.250 3.137.259 3.506.019 3.602.640 3.568.131 4.470.247 5.942.862 8.371.962 7.580.615
Gross Profit/Loss - EUR 28.621 30.469 121.114 233.515 220.477 441.928 408.586 490.282 841.354 463.233
Net Profit/Loss - EUR 28.621 30.469 114.000 193.391 184.733 380.141 351.108 421.500 697.917 348.289
Employees 24 24 0 32 31 31 32 35 36 37
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -13.5%, from 9.170.729 euro in the year 2023, to 7.892.537 euro in 2024. The Net Profit decreased by -345.728 euro, from 697.917 euro in 2023, to 348.289 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Meditrina Pharmaceuticals S.r.l.

Rating financiar

Financial Rating -
MEDITRINA PHARMACEUTICALS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Meditrina Pharmaceuticals S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Meditrina Pharmaceuticals S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Meditrina Pharmaceuticals S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Meditrina Pharmaceuticals S.r.l. - CUI 22968491

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 19.000 21.164 25.404 23.394 21.252 28.230 32.356 37.638 35.577 37.797
Current Assets 2.344.298 2.312.298 2.764.118 3.127.563 3.499.122 4.077.059 6.161.626 6.909.678 7.309.418 5.804.938
Inventories 331.038 347.136 261.732 336.854 366.974 415.220 1.428.639 1.805.838 1.739.676 871.883
Receivables 1.991.980 1.949.230 2.438.566 2.750.655 3.012.094 3.623.341 4.718.641 4.977.393 5.560.425 4.907.542
Cash 21.280 15.932 63.820 40.054 120.055 38.498 14.347 126.447 9.317 25.512
Shareholders Funds 524.704 391.217 366.005 506.736 681.656 896.110 990.929 1.089.526 1.544.184 845.252
Social Capital 1.217.244 1.204.830 1.184.738 1.162.996 1.140.473 431.664 219.849 220.531 219.863 218.634
Debts 1.995.672 2.140.391 2.549.452 2.770.513 3.025.183 3.210.645 5.219.932 6.008.298 5.802.185 4.917.745
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.804.938 euro in 2024 which includes Inventories of 871.883 euro, Receivables of 4.907.542 euro and cash availability of 25.512 euro.
The company's Equity was valued at 845.252 euro, while total Liabilities amounted to 4.917.745 euro. Equity decreased by -690.302 euro, from 1.544.184 euro in 2023, to 845.252 in 2024.

Risk Reports Prices

Reviews - Meditrina Pharmaceuticals S.r.l.

Comments - Meditrina Pharmaceuticals S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.